Magic mushrooms tested as PTSD treatment at johns hopkins
NCT ID NCT06407635
Summary
This small, early-stage study at Johns Hopkins University is testing whether psilocybin, the active compound in 'magic mushrooms,' is safe and can help reduce symptoms of chronic PTSD. The study involves 20 adults who are already taking standard antidepressant medication. Researchers will also explore whether adding specific trauma-focused talk therapy alongside the psilocybin sessions makes the treatment more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Center for Psychedelic and Consciousness Research
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.